These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21061833)

  • 21. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.
    Hermans MP; De Coster O; Seidel L; Albert A; Van de Borne P
    Blood Press Suppl; 2009 Oct; 1():5-14. PubMed ID: 20050100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study.
    Schmidt AC; Graf C; Brixius K; Scholze J
    Clin Drug Investig; 2007; 27(12):841-9. PubMed ID: 18020542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
    Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
    Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
    Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
    Bakris G; Hester A; Weber M; Dahlof B; Pitt B; Velasquez E; Staikos-Byrne L; Shi V; Jamerson K;
    J Cardiometab Syndr; 2008; 3(4):229-33. PubMed ID: 19040592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y; Arnott W
    J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension.
    Peter P; Martin U; Sharma A; Dunne F
    J Clin Pharm Ther; 2006 Apr; 31(2):153-9. PubMed ID: 16635049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of safety and antihypertensive efficacy of a cardioselective beta-blocker nebivolol in patients with hypertension and concomitant chronic obstructive bronchitis].
    Iakushin SS; Okorokov VG; Liferov RA; Fomina VA; Ivanova GO
    Kardiologiia; 2002; 42(11):36-9. PubMed ID: 12494034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
    Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of nebivolol in patients with mild and moderate hypertension].
    Zhigunova LV; Lakhova EL; Iurenev AP
    Ter Arkh; 2003; 75(3):59-61. PubMed ID: 12718224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
    Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.